benign prostatic hypertrophia overactive bladder
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Male patients treated in the department of Urology of the Amsterdam Medical Center (AMC) of any age. Any patient that receives any kind of treatment in which prostate tissue is harvested and and not required for pathological analysis.
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main study parameters/endpoints: Genotype for the polymorphism in the M2 receptor gene promoter will be related to abundance of M2 receptor mRNA in prostatic tissue; mRNA for housekeeping genes and for other muscarinic receptor subtypes will be internal controls | — |
Countries
Netherlands
Outcome results
None listed